Skip to main content

Cross Country Healthcare Aktie - Fundamentalanalyse - Dividendenrendite KGV

Cross Country Healthcare (ISIN: US2274831047, WKN: 550897) Kursdatum: 22.11.2017 Kurs: 13,440 USD
Beschreibung Daten
Symbol CCRN
Marktkapitalisierung 487.146.240,00 USD
Land Vereinigte Staaten von Amerika
Indizes NASDAQ Comp.
Sektor Gesundheitswesen
Rohdaten nach US GAAP in Millionen USD
Aktiensplits
Internet www.crosscountryhealthcare.com
Letztes Bilanz Update 03.03.2017

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 22.11.2017
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
20,62 16,16 0,00% 2,05 38,94 61,15 0,58 3,22

Firmenbeschreibung

Quarterly Financial Data (Unaudited) FirstQuarter SecondQuarter ThirdQuarter FourthQuarter2015(amounts in thousands, except per share data)Revenue from services$185,964 $192,617 $195,692 $193,148        Gross profit47,037 48,363 51,486 50,479        Consolidated net income (loss)3,050 2,680 5,151 (5,927)        Net income (loss) attributable to common shareholders2,934 2,573 5,009 (6,098)        Net income (loss) per share attributable to common shareholders - Basic $0.09 $0.08 $0.16 $(0.19)        Net income (loss) per share attributable to common shareholders - Diluted$0.05 $0.08 $0.16 $(0.19)  FirstQuarter SecondQuarter ThirdQuarter FourthQuarter2014(amounts in thousands, except per share data)Revenue from services$118,091 $122,656 $188,944 $188,134        Gross profit30,450 32,436 47,277 47,641        Consolidated net loss(782) (3,181) (7,484) (20,087)        Net loss attributable to common shareholders(782) (3,181) (7,602) (20,218)        Net loss per share attributable to common shareholders - Basic and Diluted$(0.03) $(0.10) $(0.24) $(0.65)________________The following items impact the comparability and presentation of our consolidated data:•The Company recorded changes in the fair value of convertible notes derivative liability, recording a gain in the first and second quarters of 2015 of $2.1 million and $0.4 million, respectively, a loss in the third and fourth quarters of 2015 of $2.9 million and $9.5 million, respectively, and a loss in the third and fourth quarters of 2014 of $7.3 million and

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.crosscountryhealthcare.com